Serum asprosin levels as a subclinical atherosclerosis marker in patients with primary hypertension
Mehmet İbrahim Özet, Fatih Acehan, Merve Kaygısız, Mustafa Abdulgani Kurt, Halil Arslan, Fatma Meriç Yılmaz, İhsan Ateş · 2026
Read Serum asprosin levels as a subclinical atherosclerosis marker in patients with primary hypertension by Mehmet İbrahim Özet, Fatih Acehan, Merve Kaygısız, Mustafa Abdulgani Kurt, Halil Arslan, Fatma Meriç Yılmaz, İhsan Ateş (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13480018.txt.
Description
Mehmet İbrahim Özet and colleagues report a 2026 study of a hormone-like protein called asprosin in people with high blood pressure. The team enrolled 114 patients with primary hypertension and 62 healthy adults of like age and sex. They measured asprosin in blood and used calcium scores from heart scans to gauge early artery disease that causes no symptoms yet.
Asprosin levels ran higher in patients than in healthy adults. Older age, higher pressure, and higher overall heart risk each tracked with more calcium in the arteries. A blood test cut-off for asprosin picked out patients with early disease with fair accuracy, near seven in ten correct in both directions. The authors treat asprosin as a clue to body-wide strain rather than a stand-alone test, and they call for larger studies that follow people over time.
Catalog record
| CREATOR | Mehmet İbrahim Özet, Fatih Acehan, Merve Kaygısız, Mustafa Abdulgani Kurt, Halil Arslan, Fatma Meriç Yılmaz, İhsan Ateş |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39157 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |